Google News – Biopharma External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals to acquire Actio Biosciences for $820 million, expanding rare epilepsy portfolio - CNBC
Google News – FDA (biotech/pharma) External News
FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issues - BioSpace
Google News – Biopharma External News
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) - PR Newswire
Google News – Oncology External News
Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 push - Fierce Biotech
Google News – Pharmaceuticals External News
Jazz Pharmaceuticals to Acquire Actio Biosciences, Expanding Rare Epilepsy Portfolio - PR Newswire
Google News – FDA (biotech/pharma) External News
FDA panel to weigh Grail’s Galleri test - statnews.com
Google News – FDA (biotech/pharma) External News
ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms - Fierce Pharma
Google News – Biopharma External News
Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost - Reuters
Google News – Oncology External News
AI Innovation Is Reshaping Cancer Care—What Do Pharma Marketers Need to Know? - Fierce Pharma
Google News – FDA (biotech/pharma) External News
Is the biotech capital of the world moving? - STAT
Google News – Biopharma External News
Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing - Yahoo Finance
Google News – Cardiology External News
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce Biotech
Google News – FDA (biotech/pharma) External News
UPDATED: Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle - fiercepharma.com
Google News – FDA (biotech/pharma) External News